| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-14 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-13 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.25 | 6e-10 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-09 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-08 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-07 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-07 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-07 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-07 |